Terms: = Sarcomas AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Clinical Outcome
7 results:
1. ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.
Pasello M; Giudice AM; Cristalli C; Manara MC; Mancarella C; Parra A; Serra M; Magagnoli G; Cidre-Aranaz F; Grünewald TGP; Bini C; Lollini PL; Longhi A; Donati DM; Scotlandi K
Cell Oncol (Dordr); 2022 Dec; 45(6):1237-1251. PubMed ID: 36149602
[TBL] [Abstract] [Full Text] [Related]
2. Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.
Nan X; Wang J; Cheng H; Yin Z; Sheng J; Qiu B; Lau CC; Yustein JT; Zhao H; Wong STC
Cancer Lett; 2020 Jan; 469():195-206. PubMed ID: 31672491
[TBL] [Abstract] [Full Text] [Related]
3. Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma.
Okada T; Lee AY; Qin LX; Agaram N; Mimae T; Shen Y; O'Connor R; López-Lago MA; Craig A; Miller ML; Agius P; Molinelli E; Socci ND; Crago AM; Shima F; Sander C; Singer S
Cancer Discov; 2016 Oct; 6(10):1148-1165. PubMed ID: 27577794
[TBL] [Abstract] [Full Text] [Related]
4. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases.
Schoolmeester JK; Howitt BE; Hirsch MS; Dal Cin P; Quade BJ; Nucci MR
Am J Surg Pathol; 2014 Feb; 38(2):176-88. PubMed ID: 24418852
[TBL] [Abstract] [Full Text] [Related]
5. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial.
Schwartz GK; Tap WD; Qin LX; Livingston MB; Undevia SD; Chmielowski B; Agulnik M; Schuetze SM; Reed DR; Okuno SH; Ludwig JA; Keedy V; Rietschel P; Kraft AS; Adkins D; Van Tine BA; Brockstein B; Yim V; Bitas C; Abdullah A; Antonescu CR; Condy M; Dickson MA; Vasudeva SD; Ho AL; Doyle LA; Chen HX; Maki RG
Lancet Oncol; 2013 Apr; 14(4):371-82. PubMed ID: 23477833
[TBL] [Abstract] [Full Text] [Related]
6. Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome.
Mora J; Rodríguez E; de Torres C; Cardesa T; Ríos J; Hernández T; Cardesa A; de Alava E
Pediatr Blood Cancer; 2012 Apr; 58(4):532-8. PubMed ID: 21994054
[TBL] [Abstract] [Full Text] [Related]
7. New medical treatment options and strategies to assess clinical outcome in soft-tissue sarcoma.
Schmitt T; Kasper B
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1159-67. PubMed ID: 19671035
[TBL] [Abstract] [Full Text] [Related]
